首页|半胱氨酸蛋白酶抑制剂C与糖尿病肾病的相关性

半胱氨酸蛋白酶抑制剂C与糖尿病肾病的相关性

扫码查看
目的 探讨半胱氨酸蛋白酶抑制剂C(Cys C)与糖尿病肾病(DKD)的相关性.方法 收集2019年1月至12月陕西省人民医院内分泌科住院的122例2型糖尿病(T2DM)患者的临床资料,按尿白蛋白与肌酐比值(UACR)分为单纯糖尿病(DM)组(UACR<30 mg/g,89例)、DKD组(UACR≥30 mg/g,33例).比较两组临床资料,采用logistic回归分析T2DM患者发生DKD的危险因素,绘制受试者操作特征(ROC)曲线评价Cys C对DKD的预测价值.结果 DKD组收缩压、碱性磷酸酶、总蛋白、球蛋白、血清肌酐、尿微量白蛋白、尿α1微球蛋白、UACR、Cys C均高于单纯DM组,病程长于单纯DM组(P<0.05).logistic回归分析显示,Cys C是DKD的危险因素(OR=28.369,95%CI:1.208~666.129,P=0.038).ROC 曲线分析显示,CysC 预测 DKD 的曲线下面积为 0.757(P<0.05).结论 Cys C与T2DM合并DKD密切相关,检测Cys C可用于评估DKD病情进展.
Correlation between cystatin C and diabetic kidney disease
Objective To investigate the correlation between cystatin C(Cys C)and diabetic kidney disease(DKD).Methods Clinical data of 122 patients with type 2 diabetes mellitus(T2DM)admitted to the Department of Endocrinology of Shaanxi Provincial People's Hospital from January to December 2019 was collected.According to the urinary albumin to creatinine ratio(UACR),patients were divided into DM group(UACR<30 mg/g,89 cases)and DKD group(UACR≥30 mg/g,33 cases),the clinical data was compared between the two groups.The risk factors of DKD in T2DM patients were analyzed by logistic regression.Receiver operating characteristic(ROC)curve was drawn to evaluate the predictive value of Cys C in the occurrence of DKD.Results Systolic blood pressure,alkaline phosphatase,total protein,globulin,serum creatinine,urinary microalbumin,urinary α1-microglobulin,UACR,and Cys C in DKD group were higher than those in simple DM group,and the course of disease was longer than that in simple DM group(P<0.05).Logistic regression analysis showed that Cys C was an risk factor for DKD(OR=28.369,95%CI:1.208-666.129,P=0.038).The ROC curve analysis showed that,the area under the curve of Cys C predictive of DKD was 0.757(P<0.05).Conclusion Cys C is closely related to T2DM with DKD,and detection of Cys C can be used to evaluate the progression of DKD.

Type 2 diabetes mellitusDiabetic kidney diseaseCystatin CUrinary albumin to creatinine ratio

梁园芳、张端倪、闫妮、惠蓉、李晓燕、苏亚

展开 >

陕西省人民医院风湿免疫科,陕西西安 710068

陕西省人民医院第三临床管理部,陕西西安 710068

陕西省人民医院内分泌科,陕西西安 710068

2型糖尿病 糖尿病肾病 半胱氨酸蛋白酶抑制剂C 尿白蛋白与肌酐比值

国家自然科学基金陕西省重点研发计划

821008302022SF-007

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(12)
  • 25